J&J, Covidien Settle Injunction Spat In Patent Row
Covidien PLC agreed to settle claims brought by a Johnson & Johnson unit that a preliminary injunction blocking sales of an ultrasonic surgical product that was later reversed caused $6.3 million...To view the full article, register now.
Already a subscriber? Click here to view full article